Defining the Role of the Monoamine Oxidase-B Inhibitors for Parkinson's Disease.
about
Kinetics of Inhibition of Monoamine Oxidase Using Curcumin and Ellagic Acid.Methylene blue and its analogues as antidepressant compounds.Individual Amino Acid Supplementation Can Improve Energy Metabolism and Decrease ROS Production in Neuronal Cells Overexpressing Alpha-Synuclein.Design and Synthesis of New Benzothiazole Compounds as Selective hMAO-B Inhibitors.Neuroprotective strategies to prevent and treat Parkinson's disease based on its pathophysiological mechanism.Pretreatment with potassium channel blockers of 4-aminopyridine and tetraethylammonium attenuates behavioural symptoms of Parkinsonism induced by intrastriatal injection of 6-hydroxydopamine; the role of lipid peroxidation.
P2860
Defining the Role of the Monoamine Oxidase-B Inhibitors for Parkinson's Disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Defining the Role of the Monoamine Oxidase-B Inhibitors for Parkinson's Disease.
@en
type
label
Defining the Role of the Monoamine Oxidase-B Inhibitors for Parkinson's Disease.
@en
prefLabel
Defining the Role of the Monoamine Oxidase-B Inhibitors for Parkinson's Disease.
@en
P2860
P1433
P1476
Defining the Role of the Monoamine Oxidase-B Inhibitors for Parkinson's Disease.
@en
P2093
Daphne Robakis
P2860
P2888
P304
P356
10.1007/S40263-015-0249-8
P50
P577
2015-07-12T00:00:00Z